| Anthony Peter Logalbo, PHD | |
|
3661 S Babcock St, Melbourne, FL 32901-8205 | |
| (321) 434-7611 | |
| (321) 727-3738 |
| Full Name | Anthony Peter Logalbo |
|---|---|
| Gender | Male |
| Speciality | Clinical Neuropsychologist |
| Location | 3661 S Babcock St, Melbourne, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255418372 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY7399 (Florida) | Secondary |
| 103G00000X | Clinical Neuropsychologist | PY7399 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Peter Logalbo, PHD 3300 S Fiske Blvd, Rockledge, FL 32955-4306 Ph: (321) 434-7611 | Anthony Peter Logalbo, PHD 3661 S Babcock St, Melbourne, FL 32901-8205 Ph: (321) 434-7611 |
News Archive
By adding the results of an imaging technique to the traditional risk factors for coronary heart disease, doctors at Baylor College of Medicine in Houston found they were able to improve prediction of heart attacks in people previously considered low risk.
Medecins Sans Frontieres, the Drugs for Neglected Diseases initiative, and the Mount Sinai School of Medicine this week are hosting a conference in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations," the Philadelphia Inquirer reports.
In the first national study of the prevalence of antibiotic-resistant Acinetobacter baumannii infections in children across the US, researchers from Center for Disease Dynamics, Economics, & Policy (CDDEP) in Washington, DC and Rush University in Chicago, IL examined national and regional trends of antibiotic resistance in clinical specimens over a 13-year period.
The American Society for Aesthetic Plastic Surgery (ASAPS) has announced that patients need to be wary of "bargain" injectables or other treatments that are not approved by the United States Food and Drug Administration (FDA). Unregulated injectables or treatments can compromise patient health and put patient lives at risk.
ULURU Inc. announced today that six posters detailing clinical experience using Altrazeal™ Transforming Powder Dressing will be presented at the 2010 Joint Conference of the Wound Ostomy and Continence Nurses Society (WOCN) and World Council of Enterostomal Therapists (WCET) on June 14-16 in Phoenix, Arizona.
› Verified 6 days ago